副鼻腔炎薬の世界市場:ステロイド点鼻薬、抗生物質、輻輳除去剤、その他の薬

◆英語タイトル:Global Sinusitis Drugs Market 2019-2023
◆商品コード:IRTNTR31452
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月19日
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、副鼻腔炎薬の世界市場について調べ、副鼻腔炎薬の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、副鼻腔炎薬の市場規模をセグメンテーション別(製品別(ステロイド点鼻薬、抗生物質、輻輳除去剤、その他の薬) )と地域別(グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ))に分けて算出しました。
・サマリー
・レポートの範囲
・副鼻腔炎薬の市場状況
・副鼻腔炎薬の市場規模
・副鼻腔炎薬の市場予測
・副鼻腔炎薬の世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(ステロイド点鼻薬、抗生物質、輻輳除去剤、その他の薬)
・副鼻腔炎薬の顧客状況
・主要地域別市場規模:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Sinusitis Drugs Market: About this market

Technavio’s sinusitis drugs market analysis considers the treatment of sinusitis using steroid nasal sprays, antibiotics, decongestants, and other drugs. Our analysis also considers the market’s growth in Asia, Europe, North America, and ROW. In 2018, steroid nasal sprays segment had a significant share market share, and this trend is expected to continue over the forecast period. Factors such as the higher therapeutic efficacy are playing a significant role in the steroid nasal sprays segment to maintain its market position. Also, our sinusitis drugs market looks at factors such as the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions. However, surgical intervention for sinusitis management, unknown etiology of sinusitis, and the launch of generics may hamper the growth of the sinusitis drugs industry over the forecast period.

Global Sinusitis Drugs Market: Overview

Rising prevalence of sinusitis

Risk factors such as the history of respiratory tract infection, structural problems within the sinus glands, and nasal polyps have increased the prevalence of sinusitis in general population. Other factors, such as allergies, pollutants, and fungal infections, also cause sinus infections. In 2017, a significant number of adults in the US were diagnosed with sinusitis. The prevalence of the infection was found to be higher in males than in females. The growing prevalence of sinusitis has increased the consumption of sinusitis treatment drugs. This is one of the key factors driving the growth of the global sinusitis drugs market size at a CAGR of over 6% during the forecast period.

Emergence of novel therapeutic approaches

The growing demand for targeted drugs for sinusitis is encouraging market vendors to develop novel therapies. Some vendors in the market are developing bacteriophage therapeutics that targets Staphylococcus aureus, including its antibiotic-resistant strains. These drugs are currently in Phase I/II stage of development. The advent of many such novel therapeutic approaches is expected to fuel the growth of the global sinusitis drugs market size.

For the detailed list of factors that will drive the global sinusitis drugs market size during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several players, the global sinusitis drugs market is fairly fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several sinusitis drug companies, that include CHIESI Farmaceutici Spa, GlaxoSmithKline Plc, Intersect ENT Inc., Merck & Co. Inc., and Sanofi.

Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: PIPELINE ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Steroid nasal sprays – Market size and forecast 2018-2023

Antibiotics – Market size and forecast 2018-2023

Decongestants – Market size and forecast 2018-2023

Other drugs – Market size and forecast 2018-2023

Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

CHIESI Farmaceutici Spa

GlaxoSmithKline Plc

Intersect ENT, Inc.

Merck & Co., Inc.

Sanofi

PART 15: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Exhibit 01: Global pharmaceuticals market

Exhibit 02: Segments of global pharmaceuticals market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Some key clinical trials for sinusitis and related comorbidities

Exhibit 18: Product – Market share 2018-2023 (%)

Exhibit 19: Comparison by product

Exhibit 20: Steroid nasal sprays – Market size and forecast 2018-2023 ($ millions)

Exhibit 21: Steroid nasal sprays – Year-over-year growth 2019-2023 (%)

Exhibit 22: Antibiotics – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Antibiotics – Year-over-year growth 2019-2023 (%)

Exhibit 24: Decongestants – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Decongestants – Year-over-year growth 2019-2023 (%)

Exhibit 26: Other drugs – Market size and forecast 2018-2023 ($ millions)

Exhibit 27: Other drugs – Year-over-year growth 2019-2023 (%)

Exhibit 28: Market opportunity by product

Exhibit 29: Customer landscape

Exhibit 30: Market share by geography 2018-2023 (%)

Exhibit 31: Geographic comparison

Exhibit 32: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: North America – Year-over-year growth 2019-2023 (%)

Exhibit 34: Top 3 countries in North America

Exhibit 35: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 37: Top 3 countries in Europe

Exhibit 38: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 40: Top 3 countries in Asia

Exhibit 41: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 42: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 43: Top 3 countries in ROW

Exhibit 44: Key leading countries

Exhibit 45: Market opportunity

Exhibit 46: Impact of drivers and challenges

Exhibit 47: Vendor landscape

Exhibit 48: Landscape disruption

Exhibit 49: Vendors covered

Exhibit 50: Vendor classification

Exhibit 51: Market positioning of vendors

Exhibit 52: CHIESI Farmaceutici Spa – Vendor overview

Exhibit 53: CHIESI Farmaceutici Spa – Business segments

Exhibit 54: CHIESI Farmaceutici Spa – Organizational developments

Exhibit 55: CHIESI Farmaceutici Spa – Geographic focus

Exhibit 56: CHIESI Farmaceutici Spa – Segment focus

Exhibit 57: CHIESI Farmaceutici Spa – Key offerings

Exhibit 58: CHIESI Farmaceutici Spa – Key customers

Exhibit 59: GlaxoSmithKline Plc – Vendor overview

Exhibit 60: GlaxoSmithKline Plc – Business segments

Exhibit 61: GlaxoSmithKline Plc – Organizational developments

Exhibit 62: GlaxoSmithKline Plc – Geographic focus

Exhibit 63: GlaxoSmithKline Plc – Segment focus

Exhibit 64: GlaxoSmithKline Plc – Key offerings

Exhibit 65: GlaxoSmithKline Plc – Key customers

Exhibit 66: Intersect ENT Inc. – Vendor overview

Exhibit 67: Intersect ENT Inc. – Business segments

Exhibit 68: Intersect ENT Inc. – Organizational developments

Exhibit 69: Intersect ENT Inc. – Key offerings

Exhibit 70: Intersect ENT Inc. – Key customers

Exhibit 71: Merck & Co. Inc. – Vendor overview

Exhibit 72: Merck & Co. Inc. – Business segments

Exhibit 73: Merck & Co. Inc. – Organizational developments

Exhibit 74: Merck & Co. Inc. – Geographic focus

Exhibit 75: Merck & Co. Inc. – Segment focus

Exhibit 76: Merck & Co. Inc. – Key offerings

Exhibit 77: Merck & Co. Inc. – Key customers

Exhibit 78: Sanofi – Vendor overview

Exhibit 79: Sanofi – Business segments

Exhibit 80: Sanofi – Organizational developments

Exhibit 81: Sanofi – Geographic focus

Exhibit 82: Sanofi – Segment focus

Exhibit 83: Sanofi – Key offerings

Exhibit 84: Sanofi – Key customers

Exhibit 85: Validation techniques employed for market sizing

Exhibit 86: Definition of market positioning of vendors



【掲載企業】

CHIESI Farmaceutici Spa、GlaxoSmithKline Plc、Intersect ENT Inc.、Merck & Co. Inc.、Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[副鼻腔炎薬の世界市場:ステロイド点鼻薬、抗生物質、輻輳除去剤、その他の薬]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆